Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Transportation, E-Commerce & Mechanical Systems
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Premex Inc. currently has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 4 distinct art units, which indicates that the company's prosecution efforts are spread across many different specialized divisions of the patent office.
Prosecution for the portfolio involves 4 distinct examiners, ensuring that each of the 4 pending office actions is handled by a unique individual. This distribution of examiners prevents any single individual from having a concentrated influence over the company's current patent applications.
PADUA, NICO LAUREN is identified as the busiest examiner for the portfolio, with 1 pending office action under review. Because the busiest examiner is responsible for 1 out of the 4 total pending actions, the company's prosecution landscape is characterized by examiner diversity across its active biotechnology and pharmaceutical filings.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (50%) |
| §103 only | 2 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PADUA, NICO LAUREN | 1 | 15.4% | +35.8% |
| BERRIOS, JENNIFER A | 1 | 37.1% | +49.3% |
| BACA, MATTHEW WALTER | 1 | 71.7% | +5.6% |
| HILL, GRACELYN MARKHAM | 1 | 50.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18673789 | METHOD AND SYSTEM FOR REAL-TIME LIVESTOCK MANAGEMENT | PADUA, NICO LAUREN | 11d overdue |
| 17884907 | SYSTEMS AND METHODS FOR IMPROVING LIVESTOCK HEALTH AND PERFORMANCE | HILL, GRACELYN MARKHAM | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18673789 | METHOD AND SYSTEM FOR REAL-TIME LIVESTOCK MANAGEMENT | PADUA, NICO LAUREN | 11d overdue |
| 17914997 | COMPOSITIONS AND METHODS FOR INCREASING DIGESTIBILITY OF CALCIUM AND PHOSPHOROUS IN PIGS | BERRIOS, JENNIFER A | 15d |
| Art Unit | Apps |
|---|---|
| 3626 | 1 |
| 1613 | 1 |
| 2857 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18673789 | METHOD AND SYSTEM FOR REAL-TIME LIVESTOCK MANAGEMENT | PADUA, NICO LAUREN | 3626 | §101§103§112 | Non-Final OA | 11d overdue | Pending | May 24, 2024 |
| 17914997 | COMPOSITIONS AND METHODS FOR INCREASING DIGESTIBILITY OF CALCIUM AND PHOSPHOROUS IN PIGS | BERRIOS, JENNIFER A | 1613 | §103 | Final Rejection | 15d | Pending | Sep 27, 2022 |
| 17800183 | VIRTUAL AND DIGITAL RESEARCH MODEL AND RELATED METHODS FOR IMPROVING ANIMAL HEALTH AND PERFORMANCE OUTCOMES | BACA, MATTHEW WALTER | 2857 | §103 | Non-Final OA | 71d overdue | Pending | Aug 16, 2022 |
| 17884907 | SYSTEMS AND METHODS FOR IMPROVING LIVESTOCK HEALTH AND PERFORMANCE | HILL, GRACELYN MARKHAM | 1685 | §101§103DP | Final Rejection | — | Pending | Aug 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPremex Inc. has 4 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Nico Lauren Padua has the most, with 1 of Premex Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
